Storey Susan, Von Ah Diane, Hammer Marilyn J
Indiana University in Indianapolis.
Mount Sinai Hospital.
Oncol Nurs Forum. 2017 Jul 1;44(4):E141-E151. doi: 10.1188/17.ONF.E141-E151.
PROBLEM IDENTIFICATION: Poor health outcomes have been associated with hyperglycemia in patients with and without diabetes. However, the impact of hyperglycemia on the health-related outcomes of patients with cancer has shown conflicting results. The purpose of this review was to explore definitions and measurement issues related to the assessment of hyperglycemia and the subsequent impact on the findings of health-related outcomes in adults with cancer. .
Four electronic databases were searched.
DATA EVALUATION: A total of 30 articles were reviewed. Quantitative articles were synthesized using integrative review strategies. .
Three key gaps were identified in the literature.
CONCLUSIONS: This review highlights the inconsistencies in measuring or assessing hyperglycemia and the lack of standardized guidelines in treating hyperglycemia. Failure to have a standard approach to the measurement and management of hyperglycemia impedes the ability of healthcare providers to determine the significance of its impact on health outcomes. Further research is needed to establish appropriate measurement guidelines to address hyperglycemia in people with cancer. .
Evidence-based measurement and treatment guidelines are needed to inform and assist healthcare providers with clinical decision making for people with cancer who experience hyperglycemia.
无论有无糖尿病，高血糖都与患者不良健康结局相关。然而，高血糖对癌症患者健康相关结局的影响呈现出相互矛盾的结果。本综述的目的是探讨与高血糖评估相关的定义和测量问题，以及其对成年癌症患者健康相关结局研究结果的后续影响。
检索了四个电子数据库。
共审查了30篇文章。采用综合综述策略对定量文章进行了综合分析。
文献中发现了三个关键空白。
本综述强调了在测量或评估高血糖方面的不一致性，以及治疗高血糖缺乏标准化指南。缺乏测量和管理高血糖的标准方法阻碍了医疗服务提供者确定其对健康结局影响的重要性的能力。需要进一步研究以建立适当的测量指南来解决癌症患者中的高血糖问题。
需要基于证据的测量和治疗指南，为经历高血糖的癌症患者的临床决策提供信息并协助医疗服务提供者。
